 您的位置：对照品 > 标准物质 > 农残标准物质 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：L175813 |
| 产品名称：Lapatinib Ditosylate Monohydrate |
| 产品CAS：388082-78-8 |
| 规格含量：2mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
L175813 |
| 名称: |
Lapatinib Ditosylate Monohydrate |
| 别名: |
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine 4-methylbenzenesulfonate hydrate; N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine bis(4-methylbenzenesulfonate) monohydrate |
| CAS号: |
388082-78-8 |
| 分子式: |
C₂₉H₂₆ClFN₄O₄S • 2(C₇H₈O₃S) • H₂O |
| 分子量: |
943.48 |
| 种类: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: |
Lapatinib ditosylate monohydrate is a form of Lapatinib I, an orally active drug for breast cancer as a dual EGFR and erbB-2 inhibitor. |
| 参考文献 |
|
|
|
|
|
|
